SEC (Securities and Exchange Commission) launches formal investigation into PolyMedica
This article was originally published in Clinica
The US Securities and Exchange Commission (SEC) has issued a formal order of investigation to PolyMedica. The company's Liberty Medical diabetes supply subsidiary is already under investigation by the FBI for fraud. Shares in PolyMedica fell 22% to $19.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.